Research programme: prolyl hydroxylase inhibitors - Kyntra Bio
Alternative Names: FG 4497; FG 4539; Research programme: HIF prolyl hydroxylase inhibitors - Kyntra BioLatest Information Update: 28 Jan 2026
At a glance
- Originator FibroGen
- Developer Kyntra Bio
- Class Small molecules
- Mechanism of Action Hypoxia-inducible factor-proline dioxygenase inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cerebral ischaemia; Ischaemia; Kidney disorders; Obesity; Sickle cell anaemia; Stroke; Wounds